Why the study?
Does apixaban resolve left ventricular thrombus in a patient following myocardial infarction?
Does apixaban resolve left ventricular thrombus in a patient following myocardial infarction?
Apixaban may be an effective alternative to traditional anticoagulation for the resolution of left ventricular thrombus following myocardial infarction.
Apixaban for LV thrombus in low-EF ACS remains hypothesis-generating; prospective trials needed before practice change.
A 68 years old male patient with history of dyslipidemia and smoking was admitted to our emergency department with complaint of dyspnea. He was transferred to the coronary care unit with the pre-diagnosis of acute coronary syndrome. In his transthoracic echocardiography, we detected anterior, anterior septal and apical wall akinesia with an LV ejection fraction (EF) of 25%, moderate mitral regurgitation and 13 × 6 mm sized thrombus in the LV. Apixaban treatment 5 mg po bid was started. In the second month transthoracic echocardiograpy, the thrombus in LV was found to have disappeared. In this report we present a patient whose LV thrombus was successfully treated after myocardial infarction by apixaban.
No takes yet. Share an insight, caveat, or question.
Yıldırım et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: